Hypobetalipoproteinemias: Clinical Trials

11 trials for Hypobetalipoproteinemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 3 Not applicable, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Active not recruiting 1, Completed 1, Unknown 1
Phase 32Completed 2
Phase 21Completed 1

Follow Hypobetalipoproteinemias: new trials by email Literature Review of Hypobetalipoproteinemias trials Research Report on Hypobetalipoproteinemias

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects
Administration of deuterated compounds for kinetic study - Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form
Not applicableUnknownMarcello Arca202022-09-302022-10-10
CArotenoid in hypoChOlesterolemia
Characterization of carotenoid status and plasma levels of oxidative stress markers in patients (case group only), Characterization, evaluation and comparison of macular pigment density - Primary Intestinal Hypocholesterolemia, Abetalipoproteinemia
CompletedHospices Civils de Lyon102022-06-302025-12-04
Prevalence of fAmilial hypobetalipopRoTeinemIa in psychiaTrIc pOpulatioN (PARTITION)
Psychiatric population - Familial Hypobetalipoproteinemia
Not applicableCompletedNantes University Hospital8962018-08-222021-09-16
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
Cosyntropin - Adrenal Insufficiency, Cirrhosis
Phase 3CompletedUniversity of Virginia1002018-01-292021-12-09
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
hypobetalipoproteinemia genetic and genotypic screening - Hypobetalipoproteinemia
Not applicableActive not recruitingNantes University Hospital4352016-01-072026-04-29
Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia
Hypobetalipoproteinemia diagnosis (LDL-C ≤ 50 mg/dL without hypolipidemic treatment) - Hypobetalipoproteinemia
CompletedNantes University Hospital30002015-05-012017-07-14
Inherited Retinal Degenerative Disease Registry
Eye Diseases Hereditary, Retinal Disease
RecruitingFoundation Fighting Blindness200002014-06-012026-05-19
Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
Tocofersolan, tocopherol alpha, Tocofersolan and tocopherol alpha - Hypobetalipoproteinemias
Phase 3CompletedHospices Civils de Lyon142011-10-012025-08-22
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
mipomersen, Placebo - Lipid Metabolism, Inborn Errors, Hyperlipidemias
Phase 2CompletedKastle Therapeutics, LLC382006-07-012016-10-21
Vitamin Replacement in Abetalipoproteinemia
Abetalipoproteinemia
CompletedNational Heart, Lung, and Blood Institute (NHLBI)12000-02-012008-03-04
Mechanisms of Low Levels of Apolipoprotein B
Cardiovascular Diseases, Heart Diseases
CompletedNational Heart, Lung, and Blood Institute (NHLBI)1997-08-012016-07-29

Narrower conditions

Abetalipoproteinemia (4)  ·  Retinitis Pigmentosa (3)  ·  Cardiovascular Diseases (2)  ·  Achromatopsia 3 (1)  ·  Adrenal Insufficiency (1)  ·  Ataxia (1)  ·  Bardet-Biedl Syndrome (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Choroideremia (1)  ·  Chylomicron retention disease (1)  ·  Color Vision Defects (1)  ·  Cone Dystrophy (1)  ·  Cone-Rod Dystrophies (1)  ·  Congenital Abnormalities (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11)  ·  Nutritional and Metabolic Diseases (11)  ·  Dyslipidemias (10)  ·  Genetic Diseases, Inborn (10)  ·  Hypolipoproteinemias (10)  ·  Lipid Metabolism Disorders (10)  ·  Lipid Metabolism, Inborn Errors (10)  ·  Metabolic Diseases (10)  ·  Metabolism, Inborn Errors (10)  ·  Eye Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Retinal Degeneration (3)  ·  Retinal Dystrophies (3)  ·  Eye Diseases, Hereditary (2)

Interventions

Cosyntropin (1)  ·  alpha-Tocopherol (1)  ·  mipomersen (1)  ·  tocophersolan (1)

Sponsors

Nantes University Hospital (3)  ·  Hospices Civils de Lyon (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Foundation Fighting Blindness (1)  ·  Kastle Therapeutics, LLC (1)  ·  Marcello Arca (1)  ·  University of Virginia (1)

Countries

France (5)  ·  United States (3)  ·  Netherlands (1)

Top investigators

Francine Welty (1)  ·  Todd Durham, PhD (1)  ·  Zachary Henry, MD (1)

Results publications

PMID 20008831, PMID 30021760

NIH funding

2005 (1), R01HL056895 (1)